CXCR4 and its ligand, SDF-1, constitute a critical axis in AML, involved in the navigation and maintenance of leukemia cells within the bone marrow niche, a sanctuary that offers protection and sustenance to both malignant and healthy hematopoietic stem cells. This evidence concerns the gene CXCL12 and acute myeloid leukemia.